pharmafield logo - pharma news

How can you maximise your primary care investment when the focus is shifting to...

Read the full article and infographics here.    The market is changing... The landscape of pharma is clearly changing rapidly – the emergence of...
pharmafield logo - pharma news

Our way: Talent attraction specialist, Gemma Sawyer, reflects on a memorable 2016 for Novo...

    What makes Novo Nordisk different? Novo Nordisk is a unique company because we really care about our social, environmental and financial responsibility...
pharmafield logo - pharma news

Global talent VP, Erica Briody, looks back on a fascinating 12 months for QuintilesIMS

  Human league: Global talent VP, Erica Briody, looks back on a fascinating 12 months for QuintilesIMS   What is QuintilesIMS and what makes...
pharmafield logo - pharma news

It has to be you: Looking for that promotion? Striving for success? Want an...

  Who is going to gain recognition, reward and achievement? Can you really leave it to someone or something else? Employment has changed. The...
pharmafield logo - pharma news

Transformers: connection, capabilities and culture in modern pharma

  Dan Masquelier, Partner, Cormis Partnership, talks about the importance of connection, capabilities and culture in a modern pharma ecosystem.   What is Cormis...
pharmafield logo - pharma news

Andrew Waiton explains why good habits start from the inside

KIE to success   Key Opinion Leaders, Thought Leaders and Key External Experts (KEE) have – for years – led best practice and influenced...
pharmafield logo - pharma news

Training your Millennials: How to measure the training investment in your Generation Y employees.

Historically, the paradigm has been that, ‘of course’ organisations should provide training for their employees. It engenders loyalty, and it is the socially responsible...

Latest articles

ViiV Healthcare's long-acting injectable HIV treatment authorised in EU

The first self-administered B-cell therapy for patients with relapsing forms of MS

Novartis receives European and UK licence for Kesimpta®▼(ofatumumab) Ofatumumab is a self-administered targeted B-cell depleting treatment option for adult patients living with relapsing forms of...
MHRA new advice on possible link between COVID-19 Vaccine AstraZeneca and blood clots

MHRA new advice on possible link between COVID-19 Vaccine AstraZeneca and blood clots

The benefits of vaccination continue to outweigh any risks but the MHRA advises careful consideration be given to people who are at higher risk...
Image of a participant being injected with breast cancer treatment

Thousands of patients set to benefit from five-minute breast cancer treatment

An injection that cuts the amount of time breast cancer patients spend in hospital from two and a half hours to as little as...

Popular articles

Image of a person descending a ladder over coronavirus to show New Normal, New Thinking: Life Post COVID-19

New Normal, New Thinking: Life Post COVID-19

New thinking will be required to adapt to the new normal life post COVID-19. I hate to start this article on a negative note, but...
ViiV Healthcare's long-acting injectable HIV treatment authorised in EU

The first self-administered B-cell therapy for patients with relapsing forms of MS

Novartis receives European and UK licence for Kesimpta®▼(ofatumumab) Ofatumumab is a self-administered targeted B-cell depleting treatment option for adult patients living with relapsing forms of...
Image of a scientist at their lab to show Study shows existing anti-parasitic drug kills coronavirus within 48 hours

Study shows anti-parasitic drug ivermectin kills coronavirus within 48 hours

A collaborative study led by the Monash Biomedicine Discovery Institute (BDI) with the Peter Doherty Institute of Infection and Immunity (Doherty Institute), a joint...
MHRA new advice on possible link between COVID-19 Vaccine AstraZeneca and blood clots

MHRA new advice on possible link between COVID-19 Vaccine AstraZeneca and blood clots

The benefits of vaccination continue to outweigh any risks but the MHRA advises careful consideration be given to people who are at higher risk...
pain relief patch released by nurofen

Nurofen launches a 24 hour ibuprofen pain relief patch

Nurofen announces the launch of the UK’s only 24 hour clinically proven pain relief patch containing ibuprofen.  Despite body pain being among the most commonly...

Subscribe

Sign up to receive your free UK subscription to Pf Magazine and our digital newsletters, for all the essential headlines, Jobs of the Week, and thought-provoking features.

Claim my free subscription